title: [Use of oral drugs and short bowel syndrome: an analysis of practices].
abstract: OBJECTIVE
  To describe drug prescription patterns in patients with short bowel syndrome (SBS).
  
  
  METHODS
  The drug prescriptions of patients suffering from SBS type 1 to 3 were compared.
  
  
  RESULTS
  Seventy-nine percent of the drugs were prescribed by oral route, and this proportion was significantly higher in patients with type 3 compared to tose with type 1. Twenty-nine percent of prescriptions were dietary supplement-drugs, 14.3% were gastrointestinal drugs and 11.4% were cardiovascular drugs. Oral prescription medications for SBS concerned many drug categories. The number of gastrointestinal or dietary supplement drugs was comparable between the 3 types. Drug doses were not increased compared with the recommendations, except for gastrointestinal drugs.
  
  
  CONCLUSIONS
  The oral administration is common and at usual dosage in patients with SBS despite a lack of studies on absorption that may help to individualize drug prescription.
authors.affiliation: INSERM U1144, Université Paris Diderot, Paris Descartes, Paris, France - Assistance Publique - Hôpitaux de Paris, Hôpital Lariboisière, Unité de recherche thérapeutique, Département de médecine interne, Paris, France.
authors.forename: Elodie
authors.initials: E
authors.lastname: Faye
authors.affiliation: Service de gastroentérologie et assistance nutritive, Pôle des maladies de l'appareil digestif, Hôpital Beaujon, Clichy, France.
authors.forename: Olivier
authors.initials: O
authors.lastname: Corcos
authors.affiliation: INSERM U1144, Université Paris Diderot, Paris Descartes, Paris, France - Assistance Publique - Hôpitaux de Paris, Hôpital Lariboisière, Unité de recherche thérapeutique, Département de médecine interne, Paris, France.
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Bergmann
authors.affiliation: INSERM U1144, Université Paris Diderot, Paris Descartes, Paris, France - Assistance Publique - Hôpitaux de Paris, Hôpital Lariboisière, Unité de recherche thérapeutique, Département de médecine interne, Paris, France.
authors.forename: Guy
authors.initials: G
authors.lastname: Simoneau
authors.affiliation: Service de gastroentérologie et assistance nutritive, Pôle des maladies de l'appareil digestif, Hôpital Beaujon, Clichy, France.
authors.forename: Francisca
authors.initials: F
authors.lastname: Joly
authors.affiliation: INSERM U1144, Université Paris Diderot, Paris Descartes, Paris, France - Assistance Publique - Hôpitaux de Paris, Hôpital Lariboisière, Unité de recherche thérapeutique, Département de médecine interne, Paris, France.
authors.forename: Célia
authors.initials: C
authors.lastname: Lloret-Linares
mesh_terms: D000284:Administration, Oral; D002317:Cardiovascular Agents / Q000008:administration & dosage; D019587:Dietary Supplements; D005260:Female; D005765:Gastrointestinal Agents / Q000008:administration & dosage; D006801:Humans; D008297:Male; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D012778:Short Bowel Syndrome / Q000503:physiopathology*
chemical_list: D002317:Cardiovascular Agents; D005765:Gastrointestinal Agents